open access

Vol 68, No 2 (2017)
MARITIME MEDICINE Review articles
Published online: 2017-06-27
Submitted: 2016-10-05
Accepted: 2017-04-28
Get Citation

Decision aid for the use of additional tests during the pre-employment medical examination (PEME) of seafarers

Alf Magne Horneland, Suzanne Louise Stannard
DOI: 10.5603/IMH.2017.0017
·
Pubmed: 28660611
·
International Maritime Health 2017;68(2):90-98.

open access

Vol 68, No 2 (2017)
MARITIME MEDICINE Review articles
Published online: 2017-06-27
Submitted: 2016-10-05
Accepted: 2017-04-28

Abstract

No laboratory tests and imaging techniques are recommended for routine use in the ILO/IMO Guidelines on the Pre-Employment Medical Examination (PEME) of Seafarers that form the basis for statutory certification. However, they are widely used as components of the PEME protocols developed by insurers, employers and national maritime authorities in an attempt to predict and reduce the risks from illness whilst working at sea. This may be justified on scientific, safety, economic or professional grounds. We propose a rational approach for deciding if and when tests can be justified for routine use in assessing a seafarer’s fitness for work at sea. This is based on well-established methods for determining the validity of screening tests in public health as well as the seafarer demographics. We do not address the well-established use of similar tests where illness is suspected but only when they are used for routine PEME screening of all seafarers.  

Abstract

No laboratory tests and imaging techniques are recommended for routine use in the ILO/IMO Guidelines on the Pre-Employment Medical Examination (PEME) of Seafarers that form the basis for statutory certification. However, they are widely used as components of the PEME protocols developed by insurers, employers and national maritime authorities in an attempt to predict and reduce the risks from illness whilst working at sea. This may be justified on scientific, safety, economic or professional grounds. We propose a rational approach for deciding if and when tests can be justified for routine use in assessing a seafarer’s fitness for work at sea. This is based on well-established methods for determining the validity of screening tests in public health as well as the seafarer demographics. We do not address the well-established use of similar tests where illness is suspected but only when they are used for routine PEME screening of all seafarers.  

Get Citation

Keywords

laboratory tests, imaging techniques, pre-employment medical examination, seafarers

About this article
Title

Decision aid for the use of additional tests during the pre-employment medical examination (PEME) of seafarers

Journal

International Maritime Health

Issue

Vol 68, No 2 (2017)

Pages

90-98

Published online

2017-06-27

DOI

10.5603/IMH.2017.0017

Pubmed

28660611

Bibliographic record

International Maritime Health 2017;68(2):90-98.

Keywords

laboratory tests
imaging techniques
pre-employment medical examination
seafarers

Authors

Alf Magne Horneland
Suzanne Louise Stannard

References (21)
  1. Guidelines on the medical examination of seafarers, Ch. XII, Paragraph (x). International Labour Office, Geneva, 2013. ISBN 9 789221 274629. http://www ilo org/wcmsp5/groups/public/@ed_dialogue/@sector/documents/normativeinstrument/wcms.
  2. Personal review of PEME protocols from Panama, Marshall Islands, Malta, Liberia, Norway, the Netherlands, Philippines DOH, Steamship, The Standard, The American Club, UK P&I Club, The Swedish Club 2016.
  3. Carter T. Seafarer medicals: population health or private gain? Int Marit Health. 2016; 67(1): 1–2.
  4. https://www.nice.org.uk/guidance/cg127.
  5. https://www.gov.uk/government/publications/the-approved-doctors-manual.
  6. https://handbook.ncmm.no.
  7. Universal Declaration of Human Rights, adopted by the United Nationas General Assembly 10th December 1948, Article. ; 23: 1.
  8. ILO/IMO Guidelines on the medical examination of seafarers. Appendix E. Introduction. ISBN 978-92-2-127463-6.
  9. Herman C. What makes a screening exam. Virtual Mentor. 2006; 8(1): 34–37.
  10. Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr. 2007; 96(3): 338–341.
  11. Graham J, Barker A. Reference Intervals. Clin Biochem Rev. 2008 Aug(Suppl 1): 93–97.
  12. Principles of Epidemiology in Public Health Practice, Third Edition, An introduction to Applied Epidemiology and Biostatistics. http://www.cdc.gov/ophss/csels/dsepd/SS1978/Lesson3/Section2.html Accessed 2016-09-23. (Accessed 2016-09-23.).
  13. Njeze GGE. Niger J Surg. PMC:3899548. 2013; 19(2): 49–55.
  14. Friedman GD, Raviola CA, Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol. 1989; 42(2): 127–136.
  15. Thistle JL, Cleary PA, Lachin JM, et al. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med. 1984; 101(2): 171–175.
  16. Shabanzadeh DM, Sørensen LT, Jørgensen T. A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study. Gastroenterology. 2016; 150(1): 156–167.e1.
  17. Afdahl, N H: Approach to the patient with incidental gallstones. www.UpToDate.com, literature review current through Sep 2016. https://www.uptodate.com/contents/approach-to-the-patient-with-incidental-gallstones?source=search_result&search=approach%20to%20the%20patient%20with%20incidental%20gallstones&selectedTitle=1~150 (Accessed 2016-10-03).
  18. Attili AF, De Santis A, Capri R, et al. The natural history of gallstones: the GREPCO experience. The GREPCO Group. PMID: 7875663. Hepatology. 1995; 21(3): 655–660.
  19. Capocaccia L, the GREPCO group. Clinical symptoms and gallstone disease: Lessons from a population study. In: Epidemiology and prevention of gallstone disease, Capocaccia L, Ricci G, Angelico F, Attili AF (Eds), Lancaster MTP Press, 1984. p.153. http://link.springer.com/chapter/10.1007%2F978-94-009-5606-3_20#page-2.
  20. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987; 7(5): 913–917.
  21. Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307:798. http://www.nejm.org/doi/full/10.1056/NEJM198209233071305.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl